<p>Chapter 1: Drug Interactions and Pharmacogenetics</p><p>François Lokiec</p><p>Chapter 2: Breast Cancer</p><p>Philippe G. Aftimos, Andrea Gombos, Lina Pugliano, Ahmad Awada, and Martine J. Piccart</p><p>Chapter 3: Lung Cancer</p><p>Stefan Zimmerman, Alessandra Curioni Fontecedro, Rolf A. Stahel, and Solange Peters</p><p>Chapter 4: Gastrointestinal Cancer: Selection of Clinically Relevant Drug-Induced Toxicities Encountered in Gastrointestinal Cancer Treatment</p><p>Julie Bogaert, Pieter-Jan Cuyle, and Eric Van Cutsem</p><p>Chapter 5: Gynecologic Cancer</p><p>Sevilay Altintas, Dirk L.A.L. Schrijvers, and Jan B. Vermorken</p><p>Chapter 6: Genitourinary Cancer</p><p>Bertrand F. Tombal</p><p>Chapter 7: Central Nervous System</p><p>Miriame Mino, Krisztian Homicsko, and Roger Stupp</p><p>Chapter 8: Bone Marrow Toxicity: Red Blood Cells</p><p>Pere Gascon</p><p>Chapter 9: Bone Marrow Toxicity: White Blood Cells</p><p>Matti S. Aapro</p><p>Chapter 10: Dermatologic Side Effects of Systemic Anticancer Therapy</p><p>Caroline Robert, Christina Mateus, and Alexander M. M. Eggermont</p><p>Chapter 11: Myeloid Malignancies</p><p>Laurent Plawny</p><p>Chapter 12: Lymphoma</p><p>Sigrid Cherrier-De Wilde</p><p>Chapter 13: Multiple Myeloma</p><p>Mario A. Dicato</p><p>Chapter 14: Preservation of Fertility in the Cancer Patient</p><p>Caroline Duhem and Fernand Ries</p><p>Chapter 15: Cardiotoxicity</p><p>Irene Braña, Esther Zamora, and Josep Tabernero</p><p>Chapter 16: Toxicity of Bone-Targeted Agents in Malignancy</p><p>Caroline Wilson, Fiona G. Taylor, and Robert E. Coleman</p><p>Chapter 17: State of the Art of Antiemetic Therapy</p><p>Sonia Fatigoni and Fausto Roila</p><p>Chapter 18: Side Effects of Nociceptive Cancer Pain Treatments in Adults</p><p>Ivan Krakowski and Aline Henry</p><p>Chapter 19: Totally Implanted Access Ports: Indications and Prevention of Complications</p><p>Didier S. Kamioner</p>